Most Recent Articles by Susan Jenks
Researchers hope to define what constitutes a functionally healthy microbiome not just in cancer, but across the health spectrum.
While liquid biopsies could prove successful in monitoring treatments, these tests might also find early-stage cancers that, left alone, would never progress.
Whether cryosurgery or cryoablation will prove a viable alternative to lumpectomy — the standard of care for women with early breast cancer — remains uncertain.
A pooled analysis of 3 combination drug regimens used to treat refractory/relapsed multiple myeloma reaffirms their safety, but does little to distinguish which approach works best.
For Merkel-cell cancers—the deadliest and rarest type—there are no approved drugs once surgery and radiation fail.
More Articles by Susan Jenks
FDA Approves Second Biosimilar Since Releasing Labeling Guidance, Despite Patent Protection, Safety ConcernsApr 28,2016
Sign Up for Free e-newsletters
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|
|Renal Cell Carcinoma||Regimens||Drugs|
Cancer Therapy Advisor Articles
- Hyperthermia Plus Chemotherapy Improves Survival in Soft Tissue Sarcoma
- Survey May Help To Identify Patients With Cancer at Risk of HBV Reactivation
- Fish Consumption and Cancer
- Socioeconomic Status May Preclude Elderly Patients From Receiving Pancreatic Cancer Treatment
- Receptor Agonists With Palonosetron May Reduce Needed Dexamethasone Duration